Novo Nordisk's new CEO, Mike Doustdar, is under significant pressure as the company contends with declining stock prices, ...

LONDON (Reuters) -Novo Nordisk’s new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its ...

Plus, inside the super secretive intelligence firm Black Cube and Pfizer takes no prisoners in its fight to buy Metsera ...

Animal health company Elanco (NYSE:ELAN) will be reporting earnings this Wednesday before market hours. Here’s what investors ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings this Wednesday before the bell. Here’s ...

Novo Nordisk is confident its bid for U.S. drugmaker Metsera doesn't raise antitrust issues. The $8.5 billion offer tops ...

Pfizer beat analysts’ revenue expectations by 7.9% last quarter, reporting revenues of $14.65 billion, up 10.3% year on year.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

The support is broad to encourage institutions to consider how to address AI-related challenges and opportunities in ways ...

U .S. pharmaceutical company Eli Lilly (LLY) has announced plans to build a $3 billion manufacturing plant in the Netherlands ...

ChatGPT maker OpenAI has signed a $38 billion (€33 billion) deal with Amazon Web Services, the latest in a string of agreements struck by the loss-making start-up as it races to secure computing power ...

Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald ...